Major Movers on December 31; LXRX, MGLN, CLF, WPI, AAPL, PPC, CALM

Shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX), a biopharmaceutical company engaged in the discovery and development of breakthrough treatments for human disease, are soaring in early trading today.

Continue reading Major Movers on December 31; LXRX, MGLN, CLF, WPI, AAPL, PPC, CALM

Major Gainers and Losers in Trading on August 24; ARUN, ADSK, MCRS, SSYS, WPI, SEB, BKH, HEI

Shares of Aruba Networks Inc. (NASDAQ: ARUN), a communications services company connecting local and remote users to corporate information technology resources via distributed enterprise networks, surged in trading today.

Continue reading Major Gainers and Losers in Trading on August 24; ARUN, ADSK, MCRS, SSYS, WPI, SEB, BKH, HEI

Orbimed Advisors Bullish on Watson Pharmaceuticals (WPI)

Orbimed Advisors, the world’s largest healthcare investment firm, is bullish on Watson Pharmaceuticals Inc. (NYSE: WPI). In a filing, Orbimed said that it added $24 million worth of WPI stock in the first quarter to its $85 million prior quarter position.

Continue reading Orbimed Advisors Bullish on Watson Pharmaceuticals (WPI)

Watson Pharmaceuticals’ Q1 Profit Beats Estimate; Shares Rise in Pre-Market Trading (WPI)

Watson Pharmaceuticals Inc. (NYSE: WPI), an integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic and brand pharmaceutical products, today, released its first-quarter financial results. WPI reported better-than-expected first-quarter profit, sending shares sharply higher in pre-market trading.

Continue reading Watson Pharmaceuticals’ Q1 Profit Beats Estimate; Shares Rise in Pre-Market Trading (WPI)